Award
Delivery Order #SPE2DR26FV9CV
Delivery Order for Amox-Clav Pharmaceutical Supply to Federal Agency
Buyer
Defense Logistics Agency
Award Amount
$32.48
Ceiling
$32.48
Awarded
March 06, 2026
Period of Performance
Mar 06, 2026 – Mar 09, 2026
Identifier
SPE2DR26FV9CV
NAICS
325411
This award is a delivery order contract issued under an existing Indefinite Delivery Vehicle (IDV) held by AmerisourceBergen Drug Corp., a leading pharmaceutical distribution company. The contract involves the procurement of a specific antibiotic medication, Amoxicillin-Clavulanate potassium suspension, in detailed dosage and packaging. The significance of this award lies in its support of federal healthcare programs by ensuring timely and reliable access to essential medications. The scope covers the delivery of the specified pharmaceutical product to the agency's facility in Conshohocken, Pennsylvania, facilitating continued treatment capabilities. This order is governed under a competitive contract vehicle previously established, reflecting the agency's ongoing commitment to efficient pharmaceutical supply chain management. The contract spans a short, well-defined performance period in early March 2026, reflecting the fulfillment of an immediate or urgent supply need. This delivery order builds on the larger IDV agreement awarded to AmerisourceBergen, which provides a long-term framework for pharmaceutical distribution to federal health initiatives.
Description
4571054789!AMOX-CLAV 600-42.9 MG/5 ML SUS 125ML